Skip to content

A verification study of psychological and physiological effect of smell of Dashi extracted from the olive-iriko (Japanese anchovy boiled by salt water with olive leaves and then dried)

A verification study of psychological and physiological effect of smell of Dashi extracted from the olive-iriko (Japanese anchovy boiled by salt water with olive leaves and then dried) - A verification study of psychological and physiological effect of smell of Dashi extracted from the olive-iriko

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031517
Enrollment
20
Registered
2018-02-28
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy women

Interventions

Suction air then testing. - Suction smell of hot water then testing. - Suction smell of Dashi extracted from the olive-iriko then testing.- Questionnaire.

Sponsors

Kamada Soy Sauce Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Females aged 26 to 40 years old. 2)Subjects who don't come with their child or children on the day of the study. 3)Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study. 4)Subjects who aren't bad at Dashi extracted from the olive-iriko (Japanese anchovy boiled by salt water with olive leaves and then dried) 5)Subjects who don't request disclosing of individual test results. 6)Subjects who won't claim to be disclosed results from the study and the measurement.

Exclusion criteria

Exclusion criteria: 1) Subjects who have smoking habit. 2) Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) 3) Subjects who are currently receiving medication due to treatment of disease. 4) In the past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. 5) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 6) Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 7) Subjects who donated over 200mL blood within the last one month, or subjects who donated over 400mL blood within the last three month. 8)Pregnant or expected pregnant, or lactating women. 9) Subjects who have symptom of dermatologic disease such as atopic dermatitis. 10) Subjects who have undergone surgery on investigation objective portion within the past 6 months. 11) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. 12) Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health / functional foods and cosmetics. 13) Others who have been determined ineligible by investigator.

Design outcomes

Primary

MeasureTime frame
1. Evaluation of autonomic nervous system 2. Evaluation of central nervous system 3. Questionnaires

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Sales & Planning Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026